Caplin Point Laboratories Limited has disclosed the consolidated voting results and scrutinizer report for its 35th Annual General Meeting (AGM) held on September 25, 2026. All six resolutions proposed in the notice were passed with the requisite majority.

The meeting was conducted through Video Conferencing/Other Audio Visual Means (VC/OAVM) at 10:00 am IST. The scrutinizer’s report, issued by M/s. Alagar & Associates LLP, confirmed that votes cast through remote e-voting and e-voting during the meeting were scrutinized in a fair and transparent manner. The total number of shareholders as on the record date was 104,458, with 50 shareholders attending the meeting through Video Conferencing.

Voting outcomes on key leadership mandates

Shareholders approved the re-appointment of Dr. Sridhar Ganesan as Managing Director and the appointment of Mr. D. Muralidharan as Whole-Time Director. The continuation of Mr. C. C. Paarthipan as Chairman was also ratified. While all resolutions passed, dissenting votes were recorded across several leadership appointments, particularly among public institutional investors.

Financial and governance resolutions

The ordinary resolutions for the adoption of financial statements for FY26 and the declaration of final dividend alongside ratification of interim dividend received overwhelming support. Dissent was minimal for these routine items, with only 0.00% of votes cast against them. However, special resolutions regarding director appointments saw higher dissent percentages, indicating varying levels of shareholder approval for specific leadership roles.

Resolution-wise voting details

The following table summarizes the voting results for each resolution as per the scrutinizer's report:

What the numbers show

A clear divergence exists between the support for routine financial matters and specific leadership appointments. While financial statements and dividends saw near-unanimous approval, the appointment of Mr. D. Muralidharan as Whole-Time Director faced the highest dissent at 3.22%. Notably, public institutional investors voted against this resolution at a rate of 38.13%, significantly higher than the overall dissent rate. This suggests that while promoter group support remained absolute (100% assent), institutional scrutiny was more pronounced regarding the new WTD appointment compared to the MD re-appointment or Chairman continuation.

Caplin Point Laboratories has scheduled its 35th Annual General Meeting for September 25, 2026. The meeting will be held via Video Conferencing or Other Audio-Visual Means at 10:00 am.

The Board has recommended a final dividend of ₹4 per equity share of face value ₹2 each. This adds to the interim dividend of ₹4 already declared, bringing the total dividend for FY26 to ₹8 per share (400%). Shareholders on record as of September 18, 2026 will be eligible for the final payout.

Key Agenda Items

The meeting agenda focuses on adopting financial statements and approving significant board-level appointments and continuations.

Board Appointments and Continuations

Three special resolutions require shareholder approval regarding the company's leadership structure:

• Re-appointment of Managing Director: Dr. Sridhar Ganesan (DIN: 06819026) seeks re-appointment as Managing Director for two years, from August 25, 2026, to August 24, 2028. His annual salary is set at ₹55,20,000, with additional perquisites subject to Schedule V limits.
• Continuation of Chairman: Mr. C. C. Paarthipan (DIN: 01218784) seeks approval to continue as Chairman and Non-Executive, Non-Independent Director despite attaining the age of 75 during his tenure. He receives no remuneration.
• Appointment of Whole-Time Director: Mr. D. Muralidharan (DIN: 08301904), currently the Chief Financial Officer, is appointed as Whole-Time Director for two years starting August 12, 2026. His annual salary is fixed at ₹62,37,600. He will continue to serve as CFO without additional compensation.

E-Voting Details

Remote e-voting opens on September 22, 2026, at 9:00 am and closes on September 24, 2026, at 5:00 pm. The cut-off date for determining voting eligibility is September 18, 2026. Members can vote via the National Securities Depository Limited platform.